I
Idorsia
The purpose of Idorsia is to discover, develop and bring more, innovative medicines to patients
At a glance
- Founded
- 2017
- Headquarters
- Allschwil, Switzerland
- Listing
- IPO 2017
- Sector
- Biotech & Life Sciences
- Power Law
- Unicorn$1–10B valuation tierThoroughbred$100M+ revenue
Knowledge graph
More headlines
Source: Dealroom Talent Intelligence.
Alumni founders
Former Idorsia employees who went on to found companies, sorted by Dealroom signal score.
ATAlentis TherapeuticsEst. 2019
Francois LamourSwitzerland
REResilienceEst. 2020
Sandy MahatmeUnited States
Lucas VançonFrance
Tobias WerkSwitzerlandGlobal footprint
team presence
across markets
Patents
167 active patent families included in this estimate.
A patent family groups patent filings for the same invention. Source: Dealroom · PatSnap.
Market sentiment
An AI-synthesised read of the highest-engagement posts about Idorsia on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Idorsia on the full Dealroom platform
Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.
